← Evidence map

ArticleKidney international reports2023

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease.

Gianluigi Zaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease. | OpenQuestion